CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows used in operating activities:
Net loss	$ (25,936)	$ (23,674)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	114	69
Amortization of intangibles	23,550	18,364
Amortization of deferred financing costs	605	793
Accretion of debt discount	871	0
Interest accretion of notes receivable	0	(48)
Deferred income tax benefit	(137)	(3,231)
Stock compensation expense	1,469	1,871
Fair market value change in derivative liability	(6,794)	0
Fair market value change in contingent consideration	(5,502)	0
(Increase) decrease in operating assets:
Accounts receivable	9,453	(714)
Income taxes	(121)	(1,264)
Inventory	(1,792)	(1,379)
Prepaid expenses and other assets	1,186	645
Increase (decrease) in operating liabilities:
Accounts payable and accrued expenses	7,453	(3,647)
Accrued allowances	(195)	(867)
Interest payable	(5,177)	(5,347)
Other liabilities	(2,366)	(615)
Net cash used in operating activities	(3,319)	(19,044)
Cash flows used in investing activities:
Purchase of software and equipment	(227)	(223)
Net cash used in investing activities	(227)	(223)
Cash flows provided by financing activities:
Payments on Treximet Secured Notes	(14,908)	0
Net (payments) drawdowns on credit facilities	(1,000)	3,313
Payments on mortgages and capital leases	(16)	(7)
Proceeds from issuance of common stock, net of tax and costs	0	144
Shares withheld for the payment of taxes	(19)	(109)
Net cash provided by (used in) financing activities	(15,943)	3,341
Net decrease in cash and cash equivalents	(19,489)	(15,926)
Cash and cash equivalents, beginning of period	56,135	34,855
Cash and cash equivalents, end of period	$ 36,646	$ 18,929